The compounds of formula 1
##STR1##
wherein R and R2 are as defined in the disclosure, are useful
in the prevention and treatment of tissue damage due to exacerbated recruitment
of polymorphonuclear neutrophils (PMN leukocytes) at the inflammatory sites.